Ben Goldacre discusses Bad Pharma (video)
Money and Finance

Ben Goldacre discusses Bad Pharma (video)


Dr. Ben Goldacre talked about his book, Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients, in which he discusses the influence of the pharmaceutical industry on the global healthcare system and argues that pharmaceutical companies hide negative studies and use questionable testing and intensive lobbying to get what they want, regardless of whether the drugs they produce are good for patients. Mr. Goldacre spoke about his book at Town Hall Seattle.

………………..

Related books:

Bad Pharma

Bad Science

Related previous post: TED Talk - Ben Goldacre: What doctors don't know about the drugs they prescribe

Related videos:

TED Talk - Ben Goldacre: Battling bad science

Ben Goldacre - "Squabbles About Homeopathy"





- Links
Kyle Bass on CNBC... Links to videos: Fight against big pharma not about just profiting: Bass Biopharma lobbying making this a big fight: Bass Kyle Bass: EMs will falter, next two years will be tough China's $3T banking loss just beginning:...

- Wake Up Newsletter: Q1 2013
Jim has just returned from San Francisco, where he was attending the JP Morgan Healthcare conference with two colleagues. This conference is in its fourth decade and is the must-have ticket for players in the bio pharma industry. Companies vie for the...

- The Depressing News About Antidepressants - By Sharon Begley
Thanks to Chris (my brother in pharmacy school) for passing this along. I love stories like this where people question conventional wisdom and the theories and studies that made it become conventional, especially when they appear to be doing objective...

- Baxter International (bax) - Dividend Stock Analysis
If you take a look at my portfolio I'm lacking in two major areas that I'd like to get more exposure too.  One is the food industry, I only have KO and MCD that are direct plays on food and the other is healthcare.  The demographics both in...

- Becton Dickinson Stock Analysis
Since I'm really lacking on health care industry exposure it was time to start looking at some of the different companies, so today we'll look at Becton Dickinson and Company.  Becton Dickinson closed trading on Monday, November 5th at $76.59....



Money and Finance








.